Article info

Download PDFPDF

Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack

Authors

  • Italia Grenga Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Center Drive, Room 8B13 MSC 1750 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Anna R. Kwilas Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Center Drive, Room 8B13 MSC 1750 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Renee N. Donahue Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Center Drive, Room 8B13 MSC 1750 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Benedetto Farsaci Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Center Drive, Room 8B13 MSC 1750 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • James W. Hodge Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Center Drive, Room 8B13 MSC 1750 20892 Bethesda MD USA PubMed articlesGoogle scholar articles

Citation

Grenga I, Kwilas AR, Donahue RN, et al
Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.